Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology and oncology.
VIDEOS
INTERVIEW WITH CEO VLAD CORIC M.D. ON CNBC’S FAST MONEY
Interview with CEO Vlad Coric M.D. on CNBC’s Mad Money
Diseases related to glutamate dysregulation